Microbix Biosystems : Earnings Document -December 20, 2023 at 11:06 pm EST
MICROBIX BIOSYSTEMS INC. ANNUAL REPORT 2023 Message to...
Source: marketscreener.com
📰 Sequel Pharma News
Sequel Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sequel Pharma. Real-time updates on events, politics, business and more.
Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market
MISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,...
Source: businessinsider.com
Microbix Biosystems Inc. Secures Funded Drug Commercialization Agreement
Microbix Biosystems Inc. announced execution of an agreement to return Kinlytic urokinase to market, initially for dissolving blood clots in venous catheters in the United States and to be followed... | May 17, 2023
United States Sequel Pharma Drug Administration Microbix Biosystems Inc Microbix Biosystems Biologics Licensing Application
Source: marketscreener.com
Microbix Secures Funded Drug Commercialization Agreement
Kinlytic® urokinase to be developed for re-entry into U.S. marketMISSISSAUGA, Ontario, May 16, 2023 -- Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter,... | May 16, 2023
Source: marketscreener.com
Microbix Biosystems : Secures Funded Drug Commercialization Agreement
Kinlytic® urokinase to be developed for re-entry into U.S. market MISSISSAUGA, CANADA, May 16, 2023 - Microbix Biosystems Inc. , a life sciences innovator,... | May 16, 2023
Source: marketscreener.com